0001493152-19-002123.txt : 20190214
0001493152-19-002123.hdr.sgml : 20190214
20190214171520
ACCESSION NUMBER: 0001493152-19-002123
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190214
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhivilo Yury
CENTRAL INDEX KEY: 0001730089
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38325
FILM NUMBER: 19608263
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc.
CENTRAL INDEX KEY: 0001661053
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330936180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-261-2900
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
3/A
1
ownership.xml
X0206
3/A
2019-02-14
2018-05-30
0
0001661053
Hancock Jaffe Laboratories, Inc.
HJLI
0001730089
Zhivilo Yury
13 RUE DE LA GARE
1100 MORGES
V8
1110
SWITZERLAND
1
0
1
0
Common Stock
4443569
I
By Biodyne Holding, S.A.
Common Stock
35012
I
By Leman Cardiovascular, S.A.
Reflects a 1-for-2 reverse stock split of the Issuer's common stock effected on December 14, 2017.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the
inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for
purposes of Section 16 or for any other purpose.
This amendment to Form 3 is being filed by the reporting person to correct the number of shares held by Biodyne Holding, S.A. on
the initial reporting date.
/s/ Yury Zhivilo
2019-02-14